The Coronavirus disease 2019 (Covid-19) is a viral respiratory infection characterized by severe acute respiratory distress syndrome [1]. It takes many clinical forms and varying degrees of severity. At the beginning of the pandemic, it was reported that children were the least affected population and mild clinical forms were the most frequent [2]. The appearance of severe pediatric forms has subverted the frozen description of this disease in children [3]. In Cameroon, few pediatric cases have been reported, due to the fact that the attention of scientists was still focused on adults. After a better sensitization many cases started being managed, mostly in urban areas like the Nkolndongo health district. The aim of this article was to describe the clinical features of Covid-19 in the pediatric population of an urban health district in Yaoundé.

A retrospective cross-sectional study was conducted for ten months, from March to December 2020 and involved 48 patients from a population of 154 suspected cases. We included all suspected Covid-19 patients aged 0 to 19 years, confirmed by the real-time RT-PCR technique targeting the viral N and ORF1 ab genes and treated in the Nkolndongo health district. The data were collected in patients’ files recruited for the purpose of a thesis of medicine entitled “Clinical picture and management of Covid-19 in the pediatric population of Nkolndongo health district”. The information was recorded in an operating sheet which included the signs and symptoms described (cough, fever, runny nose, nasal congestion, sore throat, fatigue, headache, ageusia, anosmia, cyanosis, respiratory distress, dyspnea, vomiting, diarrhea, myalgia), degrees of severity and survival at the end of treatment. All data collected were kept confidential; only investigators had access to anonymous patient data. Incomplete files were excluded. Prior to this research, we received the ethical clearance of the ethics committee of the Faculty of Medicine and Biomedical Sciences of the University of Yaoundé I. The severity of the disease was classified into four groups (asymptomatic, mild, moderate, and severe) according to the 2020 recommendations of the Cameroon Public health emergencies scientific council. The term “asymptomatic” was used to describe a patient tested positive and showing with no symptoms. The mild form included patients with uncomplicated upper respiratory tract infection associated or not with ageusia and anosmia. The moderate grade concerned patients presenting with signs of upper respiratory tract infection and respiratory distress The severe form designated cases of upper respiratory tract infection complicated with danger signs (cyanosis, inability to feed, lethargy coma, convulsion, SaO₂ < 90%) The results were analyzed by IBM SPSS.23.0 software. Data were expressed as frequencies, means and percentages. The threshold of statistical significance was set at 0.05.

The clinical findings of our cohort were: cough (58.33%), fever (54.16%), runny nose (27.1%) and were superimposable to those found in Asia and Africa [4] [5]. The predominance of these symptoms could be explained by the pathogenesis of the SARS-CoV2 virus, which mainly infects the epithelium of the respiratory tract by binding to ACE2 receptors [4]. The most symptomatic age group was that of adolescents between 13 and 19 years old. This can be justified by the large distribution of adolescents in our sample. They present immunity patterns close to those of adults with slow cell regeneration and epithelial renewal mechanisms [6]. Infants were the least symptomatic probably due to the difficulty in collecting complaints in children of this age. Most of the subjects in our cohort had a mild infection (47.93%) and 39.58% were asymptomatic: suggesting that children have fewer serious infections than adults [2]. Our results differ from the Canadian findings where the majority of subjects (68%) developed severe forms and those from Nigeria where asymptomatic forms (60.4%) were most common [4] [7]. The survival rate in our series was 100% and confirms the good prognosis associated with pediatric Covid-19 infection in Africa [4] [5] [8]. In our series, patients with comorbidity had a predisposition to develop moderate to severe forms: this is similar to a Brazilian study which found that the presence of comorbidity was associated with a high risk of death [9]. That can be explained by the low incomes in sub-saharian countries, exposing the population to delayed diagnosis and treatment.

The principal limitation of this study was the sample size, due to the fact that it was conducted in a single health district. Another limitation was the duration of the study that did not allow us to include more cases.

At the end of our study, it emerged that the clinical features were mainly fever, cough and running nose which may or may not be associated. After treatment, all the patients recovered. There was a significant association between the presence of comorbidity and moderate to severe severity.

The authors thank the management and staff of the Nkoldongo Health District for the cooperation and support.

The authors declare no conflicts of interest regarding the publication of this paper.

Claude-Audrey, M., Eric, N.E., Isabelle, M.N., Mireille, K.G.C., Nelly, K.N., Adèle-Rose, N.N., Paul, O., Carlin, N.M. and Paul, K.N. (2022) Pediatric Clinical Features of Covid-19 in Cameroon. Open Journal of Pediatrics, 12, 231-237. https://doi.org/10.4236/ojped.2022.121025